RPS6KB1 and Insulin resistance: Furthermore, mTORC1 promotes adipogenesis through the activation of S6K1, which controls the expression of early adipogenic transcription factors, causing adipose tissue expansion, the main risk factor for developing insulin resistance, and thus, of T2DM.